Adam S. Grossman, President, CEO, and Interim CFO at ADMA BIOLOGICS, INC. (ADMA), sold 570,000 shares at $10.72 ($2.5M) on 2024-06-14, disclosed to the SEC on 2024-06-14.
Open-market sale of $2.5M ADMA by President, CEO, and Interim CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $3.21 | 460,000 | $1.5M | 57.9% |
| 3 | $10.72 | 100,000 | $1.1M | 42.1% |
| Total | $4.47 avg | 570,000 | $2.5M | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |